MicrobiologybioRxivPreprint
Preclinical antiviral study of a liver-targeted TLR1/2 agonist in an immune-competent mouse model of HBV infection
Fanny Charriaud, Myriam Lamrayah, Romain Barnault…·David Durantel
This study evaluates a liver-targeted TLR1/2 agonist nanoparticle formulation for HBV treatment, showing enhanced antiviral effects compared to free agonist in mice.
DOI 10.64898/2026.05.27.728102